CD112 variant immunomodulatory proteins and uses thereof
US11834490B2 · kind B2 · utility
0Cited by
74References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 2017 |
| Grant date | Dec 5, 2023 |
| Priority date | — |
| Expiry date | Apr 5, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2510/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are immunomodulatory proteins comprising variant CD112 and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.